You just read:

AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress

News provided by

AFYX Therapeutics

Oct 09, 2019, 03:00 ET